Evidence map›Paper›PMID 26929328›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Biophysical principles predict fitness landscapes of drug resistance.

João V Rodrigues, Shimon Bershtein, Anna Li, Elena R Lozovsky, Daniel L Hartl, Eugene I Shakhnovich

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
21.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 178 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Chaperonin recognition of protein dynamics drives drug resistance.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Deconstructing empirical fitness seascapes across scales of granularity.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Bioengineering hybrid artificial life.Frontiers in bioinformatics · 2025
    Review
  16. Concepts and Methods for Predicting Viral Evolution.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  17. Concepts and methods for predicting viral evolution.bioRxiv : the preprint server for biology · 2024
    Article
  18. Article
  19. Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

João V RodriguesDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138;ORCID http://orcid.org/0000-0002-5605-656X
Shimon BershteinDepartment of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel;
Anna LiDepartment of Organismic and Evolutionary Biology, Harvard University, Cambridge MA 02138.
Elena R LozovskyDepartment of Organismic and Evolutionary Biology, Harvard University, Cambridge MA 02138.
Daniel L HartlDepartment of Organismic and Evolutionary Biology, Harvard University, Cambridge MA 02138 dhartl@oeb.harvard.edu shakhnovich@chemistry.harvard.edu.
Eugene I ShakhnovichDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138; dhartl@oeb.harvard.edu shakhnovich@chemistry.harvard.edu.
Harvard University · USBen-Gurion University of the Negev · IL

Funding

Study of Biological Evolution of Structure and Function in ProteinsR01GM068670 · NIGMS · HARVARD UNIVERSITY · PI SHAKHNOVICH, EUGENE I · 2004 to 2020
$7.0M
Evolutionary medicine in the development of antimalaria drugsR01AI106734 · NIAID · HARVARD UNIVERSITY · PI HARTL, DANIEL L · 2014 to 2017
$1.6M
NIAID NIH HHS AI106734NIAID NIH HHS R01 AI106734NIGMS NIH HHS GM068670NIGMS NIH HHS R01 GM068670
6 · The paper itself

Abstract

Fitness landscapes of drug resistance constitute powerful tools to elucidate mutational pathways of antibiotic escape. Here, we developed a predictive biophysics-based fitness landscape of trimethoprim (TMP) resistance for Escherichia coli dihydrofolate reductase (DHFR). We investigated the activity, binding, folding stability, and intracellular abundance for a complete set of combinatorial DHFR mutants made out of three key resistance mutations and extended this analysis to DHFR originated from Chlamydia muridarum and Listeria grayi We found that the acquisition of TMP resistance via decreased drug affinity is limited by a trade-off in catalytic efficiency. Protein stability is concurrently affected by the resistant mutants, which precludes a precise description of fitness from a single molecular trait. Application of the kinetic flux theory provided an accurate model to predict resistance phenotypes (IC50) quantitatively from a unique combination of the in vitro protein molecular properties. Further, we found that a controlled modulation of the GroEL/ES chaperonins and Lon protease levels affects the intracellular steady-state concentration of DHFR in a mutation-specific manner, whereas IC50 is changed proportionally, as indeed predicted by the model. This unveils a molecular rationale for the pleiotropic role of the protein quality control machinery on the evolution of antibiotic resistance, which, as we illustrate here, may drastically confound the evolutionary outcome. These results provide a comprehensive quantitative genotype-phenotype map for the essential enzyme that serves as an important target of antibiotic and anticancer therapies.

Indexed as

Amino Acid SequenceBiophysicsChlamydia muridarumDirected Molecular EvolutionDrug Resistance, BacterialEnzyme StabilityEpistasis, GeneticEscherichia coliEscherichia coli ProteinsInhibitory Concentration 50ListeriaMolecular Sequence DataMutationTetrahydrofolate DehydrogenaseTrimethoprimEscherichia coli ProteinsTetrahydrofolate DehydrogenaseTrimethoprimDHFRdrug resistancefitness landscapesmolten globuleprotein stability

Identifiers

PMID26929328
PMCPMC4801265
OpenAlexW2290502424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.